Industry-Leading Expertise in ADCs and Microbial Drug Manufacturing with a Commitment to Net-Zero by 2040.

Specializing in the production of oral solids, sterile injectables, and biologic drug products, this company leverages decades of expertise to deliver comprehensive contract manufacturing solutions. Their team is dedicated to optimizing manufacturing processes with a focus on high-quality outcomes, ensuring that every drug produced adheres to the highest global standards. Their capabilities extend from handling ADCs and microbial drug substances to providing scalable production and innovative release profiles across diverse pharmaceutical platforms and technologies. By integrating seamless process optimization and rigorous intellectual property protection, the company empowers clients to advance their drug production projects with confidence, contributing significantly to improved patient outcomes worldwide.

With a proven track record of reliability and regulatory excellence, this organization is backed by an extensive global network and a parent company with a rich history of over 170 years in the industry. The company’s leadership is composed of seasoned professionals who offer robust support across all facets of drug development, from technical services to supply chain management and regulatory affairs. The company is committed to sustainability, aligning with global standards such as cGMP, FDA, and EMA, while also sharing a goal to achieve the Net-Zero Standard by 2040. With a reputation for excellence, the organization continues to receive accolades, including the Outsourced Pharma and Life Science Leaders CDMO Leadership Award, exemplifying their steadfast dedication to advancing drug manufacturing and swiftly delivering life-changing therapies to patients worldwide.